...
首页> 外文期刊>Frontiers in Public Health >Glycosmis pentaphylla (Rutaceae): A Natural Candidate for the Isolation of Potential Bioactive Arborine and Skimmianine Compounds for Controlling Multidrug-Resistant Staphylococcus aureus
【24h】

Glycosmis pentaphylla (Rutaceae): A Natural Candidate for the Isolation of Potential Bioactive Arborine and Skimmianine Compounds for Controlling Multidrug-Resistant Staphylococcus aureus

机译:Glycosmis pentaphylla(Rutaceae):用于隔离潜在的生物活性树状藻和Skimminine化合物的天然候选者,用于控制多药耐金黄色葡萄球菌

获取原文

摘要

Several multidrug-resistant organisms have emerged which increases the threat to public health around the world and a limited number therapeutics were available to counteract these issues. Thus, the researchers are trying to find out novel antimicrobials to overcome multidrug-resistant issues. The present study aimed to isolate antibacterial principles against the clinical isolates of multidrug-resistant Staphylococcus aureus from the ethyl acetate extract of Gycosmis pentaphylla. The isolation and structural characterization of bioactive compounds were carried out using various chromatographic techniques (TLC, column, HPLC, and LC-MS) and spectral studies such as FT-IR, CHNS analysis, 1H-NMR, and 13C-NMR. The antimicrobial potential of isolated compounds was assessed according to the standard methods. The isolated compounds were identified as arborine and skimmianine which exhibited the significant antibacterial effect with lowest MIC and MBC values against MDR S. aureus and in-vitro kinetic and protein leakage assays supported the antimicrobial activity. Significant morphological changes such as uneven cell surfaces and morphology, cell shrinkage and cell membrane damages were observed in the MDR S. aureus upon the treatment of arborine and skimmianine. The present investigation concludes that the isolated arborine and skinmmianine compounds from G. pentaphylla, harbor a strong antibacterial activity against MDR S. aureus and may be used as alternative natural drugs in the treatment of MDR S. aureus.
机译:已经出现了几种多药物的有机体,这增加了对世界各地的公共卫生的威胁,并且可以获得有限的数量治疗方法来抵消这些问题。因此,研究人员正试图发现新的抗菌药物来克服多药抗性问题。本研究旨在将抗菌原理与来自Gycosmis浮动浮率的乙酸乙酯提取物中的多药抗性葡萄球菌的临床分离物分离。使用各种色谱技术(TLC,柱,HPLC和LC-MS)和光谱研究,例如FT-IR,CHNS分析,1H-NMR和13C-NMR进行生物活性化合物的分离和结构表征。根据标准方法评估分离的化合物的抗微生物潜力。将分离的化合物鉴定为树林和斯基姆氏藻,其表现出与MDR S. AURES和体外动力学和体外动力学和蛋白质泄漏测定的显着抗菌作用和MBC值支持的抗微生物活性。在治疗植物和斯博姆氏菌的MDR S.金黄色葡萄球菌中观察到诸如不均匀细胞表面和形态,细胞收缩和细胞膜损伤的显着形态学变化。本次调查得出结论,来自G.Pentaphylla的分离的植物和皮肤和皮肤化合物,涉及对MDR S.金黄色葡萄球菌的强烈抗菌活性,并且可以用作治疗MDR S.金黄色葡萄球菌的替代天然药物。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号